Paper12401733
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Lonn E and 11 others. Diabetes Care, 2002. Cited by 277 papers, by iCite.
Cite this record
ConductScience Library. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Papers, record 12401733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12401733
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
- PubMed
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Diabetic Angiopathies | Major topic |
| Vitamin E | Major topic |
| Aged | |
| Diabetes Mellitus, Type 1 | |
| Diabetes Mellitus, Type 2 | |
| Female | |
| Glycated Hemoglobin | |
| Heart Diseases | |
| Humans | |
| Male | |
| Myocardial Infarction | |
| Placebos | |
| Stroke | |
| Survival Rate | |
| Treatment Outcome |
Source PubMed
Cited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 277 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41164370 | Comprehensive dietary antioxidant index and chronic kidney disease: mediating role of frailty and its impact on mortality outcomes in adults. | Front Nutr | 2025 | https://conductscience.org/library/papers/41164370 | PubMed |
| 41015637 | Diabetic cardiomyopathy: Mechanistic insights on molecular pathways and emerging therapeutic approaches. | Heart Fail Rev | 2025 | https://conductscience.org/library/papers/41015637 | PubMed |
| 40437093 | CoQ imbalance drives reverse electron transport to disrupt liver metabolism. | Nature | 2025 | https://conductscience.org/library/papers/40437093 | PubMed |
| 38682786 | Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. | Cochrane Database Syst Rev | 2024 | https://conductscience.org/library/papers/38682786 | PubMed |
| 38525444 | Evaluation of plasma vitamin E and development of proteinuria in hypertensive patients. | J Transl Int Med | 2024 | https://conductscience.org/library/papers/38525444 | PubMed |
| 38292764 | Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38292764 | PubMed |
| 37920777 | Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience. | Can J Kidney Health Dis | 2023 | https://conductscience.org/library/papers/37920777 | PubMed |
| 37916745 | Antioxidants for adults with chronic kidney disease. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37916745 | PubMed |
| 37466151 | Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease. | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/37466151 | PubMed |
| 37347448 | Dose-response relationship between dietary antioxidant intake and diabetic kidney disease in the US adults with diabetes. | Acta Diabetol | 2023 | https://conductscience.org/library/papers/37347448 | PubMed |
| 37262088 | Redox regulation in diabetic kidney disease. | Am J Physiol Renal Physiol | 2023 | https://conductscience.org/library/papers/37262088 | PubMed |
| 37107272 | Clinical Relevance of lncRNA and Mitochondrial Targeted Antioxidants as Therapeutic Options in Regulating Oxidative Stress and Mitochondrial Function in Vascular Complications of Diabetes. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107272 | PubMed |
| 36742461 | Lysosomal dysfunction in diabetic cardiomyopathy. | Front Aging | 2023 | https://conductscience.org/library/papers/36742461 | PubMed |
| 36296376 | The Role of Diacylglycerol Kinase in the Amelioration of Diabetic Nephropathy. | Molecules | 2022 | https://conductscience.org/library/papers/36296376 | PubMed |
| 35977907 | NADPH oxidase inhibitor development for diabetic nephropathy through water tank model. | Kidney Res Clin Pract | 2022 | https://conductscience.org/library/papers/35977907 | PubMed |
| 35563363 | Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563363 | PubMed |
| 35318511 | Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/35318511 | PubMed |
| 35216280 | Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis-Driver of Insulin Resistance and Development of Vascular Complications of Diabetes. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216280 | PubMed |
| 34831168 | Mitochondria in Diabetic Kidney Disease. | Cells | 2021 | https://conductscience.org/library/papers/34831168 | PubMed |
| 34646830 | Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34646830 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12401733
GET https://conductscience.org/api/papers/v1/12401733/cited_by?page=2